Assessing resistance to the echinocandin antifungal drug caspofungin in Candida albicans by profiling mutations in FKS1
about
Mechanisms of Candida biofilm drug resistanceCandida infections, causes, targets, and resistance mechanisms: traditional and alternative antifungal agentsComparison of echinocandin antifungalsHsp90 governs echinocandin resistance in the pathogenic yeast Candida albicans via calcineurinHsp90 governs dispersion and drug resistance of fungal biofilmsThe Hsp90 co-chaperone Sgt1 governs Candida albicans morphogenesis and drug resistanceGlobal analysis of the evolution and mechanism of echinocandin resistance in Candida glabrataA phenylalanine to serine substitution within an O-protein mannosyltransferase led to strong resistance to PMT-inhibitors in Pichia pastorisMetal Chelation as a Powerful Strategy to Probe Cellular Circuitry Governing Fungal Drug Resistance and MorphogenesisAntifungal Therapy: New Advances in the Understanding and Treatment of MycosisEpidemiology of invasive candidiasis: a persistent public health problemStimulation of chitin synthesis rescues Candida albicans from echinocandins.Anidulafungin and voriconazole in invasive fungal disease: pharmacological data and their use in combination.Isolation, molecular identification, and antifungal susceptibility profiles of vaginal isolates of Candida species.Breakthrough invasive candidiasis in patients on micafungin.Target enzyme mutations confer differential echinocandin susceptibilities in Candida kefyrMolecular and nonmolecular diagnostic methods for invasive fungal infections.Regulatory circuitry governing fungal development, drug resistance, and disease.Canadian clinical practice guidelines for invasive candidiasis in adults.Elucidating drug resistance in human fungal pathogens.FKS2 mutations associated with decreased echinocandin susceptibility of Candida glabrata following anidulafungin therapy.Micafungin in the treatment of invasive candidiasis and invasive aspergillosisDisseminated Candidiasis caused by Candida albicans with amino acid substitutions in Fks1 at position Ser645 cannot be successfully treated with micafungin.Development of echinocandin resistance in Clavispora lusitaniae during caspofungin treatment.Fitness and virulence costs of Candida albicans FKS1 hot spot mutations associated with echinocandin resistance.Plant-derived antifungal agent poacic acid targets β-1,3-glucan.Elevated cell wall chitin in Candida albicans confers echinocandin resistance in vivo.Quick Detection of FKS1 Mutations Responsible for Clinical Echinocandin Resistance in Candida albicans.Pharmacology and metabolism of anidulafungin, caspofungin and micafungin in the treatment of invasive candidosis: review of the literatureEpidemiology and antifungal resistance in invasive candidiasis.Inhibitory Effect of Sophorolipid on Candida albicans Biofilm Formation and Hyphal Growth.Rapid development of Candida krusei echinocandin resistance during caspofungin therapy.Acquired Multidrug Antifungal Resistance in Candida lusitaniae during Therapy.Increase of virulence and its phenotypic traits in drug-resistant strains of Candida albicans.Stepwise development of a homozygous S80P substitution in Fks1p, conferring echinocandin resistance in Candida tropicalis.Rapid detection of triazole antifungal resistance in Aspergillus fumigatus.The echinocandins.Detection of caspofungin resistance in Candida spp. by Etest.The pharmacology and clinical use of caspofungin.The use of caspofungin in HIV-infected individuals.
P2860
Q26827521-97DF6588-1B4B-4F84-8B0B-36FDE1206055Q26863344-BECDDCD1-888E-41D8-A312-40CCE73D62D0Q28273738-01A81F2C-05F6-480F-9C94-71E3647FCCBEQ28475818-57E9F4AD-153D-4FE1-8BC2-CEB90B490757Q28476836-547F2BF7-A480-446F-8AD5-A3E69593F7EFQ28483590-60050C0E-DF23-42ED-981F-9107176B3670Q28483785-6EC68A13-51E9-4AFA-9197-32E5D49A3647Q28487786-A8D6B749-5635-4354-B96E-7BD9A5FD1259Q28554456-815BEB7F-A7BC-4870-9883-D4BD1EEE186CQ28818603-CBF29925-C4BF-419F-8C60-20FFBE17751EQ29616758-6ED22456-4B40-4646-AEC2-8194564E305FQ33326983-A700D0BF-7FEF-40CC-8C05-7A31761855D6Q33490772-B85CAA3B-9585-4F2E-BC7C-61C8CAA2A15CQ33645341-796502FA-ED22-4D86-A8CE-F8F1AB1E2F8CQ33963538-DA1FE32C-56EA-4A1C-AB21-DDAB797D1799Q34057480-8307C99E-A6C1-4624-A3DD-43ECD2E63C02Q34057660-C58B05DC-1DDE-42BC-BC91-A1FD2FDF9129Q34190284-2FDF895B-25E6-4D1A-BF9D-BF2A363478DCQ34237335-8BDF0497-5261-4B33-835B-FA58F2D6252EQ34419351-03BFFED8-1B56-4111-A50F-EF60B8889194Q34737334-2FCD5CFE-82ED-4781-B1A0-A981AF622030Q35026516-60210C92-7FD5-4F30-A42B-887582F5B019Q35065859-369DF87A-01E5-4015-93B7-DCEAB9596060Q35066753-D1DB17B2-C2FA-4AE7-A315-03929996BC13Q35129428-64159844-894C-4E05-8CC4-EEBE92F765FCQ35229373-C42CC16E-5EDA-4398-8A76-8864D2C0F55CQ35666505-ECA8A32F-C843-4C8D-8C45-4606E8336B2AQ35757564-0CD58F37-E4A6-486F-A349-C7CDA49AE115Q35959484-339FC239-8654-4EDF-BB49-F3F3C4FAB161Q35959495-E650F86C-C1B8-450E-93E6-B11D1619800BQ35974693-8AA82081-3772-4360-86B6-9610112AAC66Q36158489-1E5155CB-C983-4631-ABBC-FCC2F6CB50BFQ36290663-F8D94B82-5697-4772-A7BE-EEADF5424728Q36482736-B40BBB92-3194-4961-B645-7C68EF37F6D7Q36505494-48AD2D81-3791-4A64-9BF5-F446D34FD6DAQ36539892-90CAD78F-FD77-4FE4-A643-551A33432851Q36742397-4C5DE297-360D-4588-9B35-EA9A648D3CC1Q36747567-1D3E1D1A-90F3-4D47-B91B-2BF8638C5440Q36788428-0DA6552F-1188-4C7B-B11A-CAA534DB2F38Q36821383-7D163E8C-3929-47DF-8D71-CBA23947EA4D
P2860
Assessing resistance to the echinocandin antifungal drug caspofungin in Candida albicans by profiling mutations in FKS1
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Assessing resistance to the ec ...... by profiling mutations in FKS1
@en
Assessing resistance to the ec ...... by profiling mutations in FKS1
@nl
type
label
Assessing resistance to the ec ...... by profiling mutations in FKS1
@en
Assessing resistance to the ec ...... by profiling mutations in FKS1
@nl
prefLabel
Assessing resistance to the ec ...... by profiling mutations in FKS1
@en
Assessing resistance to the ec ...... by profiling mutations in FKS1
@nl
P2093
P2860
P356
P1476
Assessing resistance to the ec ...... by profiling mutations in FKS1
@en
P2093
David S Perlin
Sergey V Balashov
Steven Park
P2860
P304
P356
10.1128/AAC.01653-05
P407
P577
2006-06-01T00:00:00Z